In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.

A new study asserts that a particular type of schistosomiasis may predispose women to contracting HIV.

The Sabin Sustainable Immunization Financing (SIF) Program was on the agenda at a symposium hosted by the Penn Center for Vaccine Ethics and Policy.

Late last month ONE launched a new campaign to increase funding for two new vaccines for pneumococcal and diarrheal diseases. The campaign video features kids asking “why bother?”

By Jacqueline Mills

Dr. Peter Hotez, Sabin’s President, recently authored an op-ed in The Hinducalling on a new modern India to “invest in neglected tropical disease (NTD) elimination efforts--including the development of drugs, diagnostics, and vaccines--that will reduce the large NTD burden in South Asia.”

While you were sleeping, you may have been protected by a bed net. While you were sleeping, the screens on your windows might have been closed, and maybe even a fan was blowing air across your body.

Dengue illness, the most common mosquito-borne viral disease in the world, has expanded from Southeast Asia to The Americas.

Sierra Leone moved closer to achievement of both the Global Immunization Vision and Strategy and Millennium Development Goals related to poverty-reduction and improved health outcomes when the nation adopted the “Reach Every Child (RED)” approach to healthcare last fall.

Pages